USANA Health Sciences Inc
![USANA Health Sciences Inc](https://api.admiralmarkets.com/trade_icons/bright-128/USNA.png)
Closed
37.5 -3.4
Overview
Share price change
24h
Min
37.5
Max
37.85
Income | 11M |
---|---|
Sales | 7.7M 221M |
EPS | 0.87 |
Profit margin | 5.318 |
Employees | 1,800 |
Recommendations | Neutral |
---|---|
12 Months Forecast | +0.8 upside |
Next Earnings | 22 Oct 2024 |
---|
Market Cap | 13M 911M |
---|---|
Previous open | 40.9 |
Previous close | 37.5 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
USANA Health Sciences Inc Chart
Related News
Peer Comparison
Price change
USANA Health Sciences Inc Forecast
Price Target
By TipRanks
0.8% upside
12 Months Forecast
Average 38 USD 0.8%
High 38 USD
Low 38 USD
Based on 1 Wall Street analysts offering 12 month price targets forUSANA Health Sciences Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.